Skip to content

Transcutanclus electrical acupoint stimulation in the role of accelerated rehabilitation after pneumonectomy and curative effect observation

Transcutanclus electrical acupoint stimulation in the role of accelerated rehabilitation after pneumonectomy and curative effect observation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009850
Enrollment
Unknown
Registered
2016-10-10
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VATS with pneumonectomy

Interventions

TEAS:Transcutanclus Electrical Acupoint Stimulation
IA:Intravenous analgesia

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. A definitive diagnosis for lung disease without other complications which needs surgery(included Lung benign and malignant tumor, tuberculosis, pulmonary bulla, emphysema, etc),and the operations are for small incision pneumonectomy; 2. ASA I-II; 3. Aged 18 to 65 years old; Gender: not limited; 4. Cardiac function, pulmonary function, liver function, renal function and blood coagulation function can tolerate lung surgery requirements, and without immune system disease before; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Local skin infection in selected acupoints or the meridians of selected acupoints with the operation; 2. Upper or lower extremity nerve injury patients; 3. Participating in other clinical trials within four weeks; 4. Who can not cooperate to complete the plan, including dysphasia,infectious disease and other medical history.

Design outcomes

Primary

MeasureTime frame
visual analog scale;Scale of postoperative nausea and vomiting;Time of postoperative exhaust and defecation;

Secondary

MeasureTime frame
Concentration of serum beta-endorphin, light brown peptide and dyna;Content of plasma cortisol and adrenaline;Adverse reactions;

Countries

China

Contacts

Public ContactChen Tongyu

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

tongchen080@sina.com+86 13917615016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026